On this episode of the Scouting For Growth podcast, Sabine VdL talks to Dr Andrée Bates, neuroscientist and founder of Eularis, an AI-centric company that serves as a catalyst for innovation in healthcare.

The pair delve into the pivot points that drive innovation, the ethical implications of widespread AI adoption, and the tangible ways in which artificial intelligence is reshaping healthcare as we know it.

KEY TAKEAWAYS         
Eularis was created to look at mathematics on commercial activities within pharmaceuticals.
Generative AI takes elements of real data, looks at the database which it’s been trained on, makes new connections and generates something new.
We’re going to have to get to a point where we have some kind of digital certificate in our voice, our video, images, that authenticates whether it’s actually us or not, almost like a digital fingerprint

BEST MOMENTS
‘AI is a broad term, there are so many different types of techniques which are classified as artificial intelligence and under each one there are different types.’
‘We can use AI to repurpose existing drugs – and this happened with Covid.’
‘I’ve recently come across AI that is predicting with very high accuracy whether a drug will be successful or not in the long term. That’s set to revolutionise the industry.’

ABOUT THE GUEST
Dr Andrée Bates stands at the intersection of artificial intelligence, healthcare, and entrepreneurship. A seasoned neuroscientist and a disruptive tech innovator, she has trailblazed the healthcare industry since the early '90s. Dr Bates founded Eularis, a vanguard firm leveraging AI to address healthcare's most pressing challenges, back in 2003. Under her leadership, Eularis has catalysed growth for all the top 50 pharmaceutical giants, driving profits and expanding market share through AI-empowered projects in clinical trials, R&D, and medical affairs.

After launching her career in academia, Dr. Bates made a seamless transition into the corporate sphere, where she continued her legacy of firsts. She is credited with establishing the world's first digital health company in the 1990s, followed by the pioneering of commercial AI applications in healthcare. This entrepreneurial spirit has positioned her as a go-to advisor for an impressive roster of healthcare CEOs.

Her influence extends to academia and industry circles alike. Dr. Bates is a sought-after guest lecturer in prestigious MBA programs including INSEAD Business School and Fordham University, where she instils the next generation with a nuanced understanding of healthcare innovation and AI. A prolific author, her works have graced peer-reviewed journals and industry reports. Her international speaking engagements span continents, ranging from Europe and North America to Asia.

Never one to limit her impact, Dr Bates actively champions female entrepreneurs worldwide. She serves as a mentor through Thrive Mentoring, contributes to the programming committee of the Healthcare Businesswomen's Association (HBA), and is a founding member of Chief, a network designed for women leaders.

Find out about Dr. Andrée Bates and Eularis

https://www.linkedin.com/in/dr-andree-bates/

https://eularis.com/

ABOUT THE HOST

Sabine is a corporate strategist turned entrepreneur. She is the CEO and Managing Partner of Alchemy Crew, a venture lab that accelerates the curation, validation, & commercialization of new tech business models. Sabine is renowned within the insurance sector for building some of the most renowned tech startup accelerators around the world working with over 30 corporate insurers & accelerating over 100 startup ventures. Sabine is the co-editor of the bestseller The INSURTECH Book, a top 50 Women in Tech, a FinTech and InsurTech Influencer, an investor & multi-award winner. 

Twitter: SabineVdL
LinkedIn: Sabine VanderLinden
Instagram: sabinevdLofficial
Facebook: SabineVdLOfficial
TikTok: sabinevdlofficial
Email: podcast@sabinevdl.com
Website: www.sabinevdl.com

On this episode of the Scouting For Growth podcast, Sabine VdL talks to Dr Andrée Bates, neuroscientist and founder of Eularis, an AI-centric company that serves as a catalyst for innovation in healthcare.
The pair delve into the pivot points that drive innovation, the ethical implications of widespread AI adoption, and the tangible ways in which artificial intelligence is reshaping healthcare as we know it.
KEY TAKEAWAYS         
<ul>
<li>Eularis was created to look at mathematics on commercial activities within pharmaceuticals.</li>
<li>Generative AI takes elements of real data, looks at the database which it’s been trained on, makes new connections and generates something new.</li>
<li>We’re going to have to get to a point where we have some kind of digital certificate in our voice, our video, images, that authenticates whether it’s actually us or not, almost like a digital fingerprint</li>
</ul>
BEST MOMENTS ‘AI is a broad term, there are so many different types of techniques which are classified as artificial intelligence and under each one there are different types.’ ‘We can use AI to repurpose existing drugs – and this happened with Covid.’ ‘I’ve recently come across AI that is predicting with very high accuracy whether a drug will be successful or not in the long term. That’s set to revolutionise the industry.’
ABOUT THE GUEST Dr Andrée Bates stands at the intersection of artificial intelligence, healthcare, and entrepreneurship. A seasoned neuroscientist and a disruptive tech innovator, she has trailblazed the healthcare industry since the early '90s. Dr Bates founded Eularis, a vanguard firm leveraging AI to address healthcare's most pressing challenges, back in 2003. Under her leadership, Eularis has catalysed growth for all the top 50 pharmaceutical giants, driving profits and expanding market share through AI-empowered projects in clinical trials, R&amp;D, and medical affairs.
After launching her career in academia, Dr. Bates made a seamless transition into the corporate sphere, where she continued her legacy of firsts. She is credited with establishing the world's first digital health company in the 1990s, followed by the pioneering of commercial AI applications in healthcare. This entrepreneurial spirit has positioned her as a go-to advisor for an impressive roster of healthcare CEOs.
Her influence extends to academia and industry circles alike. Dr. Bates is a sought-after guest lecturer in prestigious MBA programs including INSEAD Business School and Fordham University, where she instils the next generation with a nuanced understanding of healthcare innovation and AI. A prolific author, her works have graced peer-reviewed journals and industry reports. Her international speaking engagements span continents, ranging from Europe and North America to Asia.
Never one to limit her impact, Dr Bates actively champions female entrepreneurs worldwide. She serves as a mentor through Thrive Mentoring, contributes to the programming committee of the Healthcare Businesswomen's Association (HBA), and is a founding member of Chief, a network designed for women leaders.
Find out about Dr. Andrée Bates and Eularis
https://www.linkedin.com/in/dr-andree-bates/
https://eularis.com/
ABOUT THE HOST
Sabine is a corporate strategist turned entrepreneur. She is the CEO and Managing Partner of Alchemy Crew, a venture lab that accelerates the curation, validation, &amp; commercialization of new tech business models. Sabine is renowned within the insurance sector for building some of the most renowned tech startup accelerators around the world working with over 30 corporate insurers &amp; accelerating over 100 startup ventures. Sabine is the co-editor of the bestseller The INSURTECH Book, a top 50 Women in Tech, a FinTech and InsurTech Influencer, an investor &amp; multi-award winner. 
Twitter: SabineVdL LinkedIn: Sabine VanderLinden Instagram: sabinevdLofficial Facebook: SabineVdLOfficial TikTok: sabinevdlofficial Email: <a href="mailto:podcast@sabinevdl.com">podcast@sabinevdl.com</a> Website: www.sabinevdl.com

There are over 140,000 FinTech ventures out there, including FinTechs, InsurTechs, HealthTechs, and WealthTechs. And the number keeps on changing every month. One statistic remains the same: 25% of these ventures have received investment and support from the financing world. 75% of these businesses still seek financing support from institutional and corporate investors alongside value-creating commercial collaboration opportunities with Global Fortune 500.

Through this podcast series, I would like to demystify the world of corporate venturing, including how corporations collaborate with growth ventures, how venture capitalists and corporate venture capitalists make investment and collaboration choices in ventures and give tech founders and entrepreneurs, the strategies, tactics, tools, and techniques to build, grow and scale their business by understanding how those with financing power think. 

So, listen in, share and comment as you see fit.

There are over 140,000 FinTech ventures out there, including FinTechs, InsurTechs, HealthTechs, and WealthTechs. And the number keeps on changing every month. One statistic remains the same: 25% of these ventures have received investment and support from the financing world. 75% of these businesses still seek financing support from institutional and corporate investors alongside value-creating commercial collaboration opportunities with Global Fortune 500.
Through this podcast series, I would like to demystify the world of corporate venturing, including how corporations collaborate with growth ventures, how venture capitalists and corporate venture capitalists make investment and collaboration choices in ventures and give tech founders and entrepreneurs, the strategies, tactics, tools, and techniques to build, grow and scale their business by understanding how those with financing power think. 
So, listen in, share and comment as you see fit.

Advertisement